Focus: Anteris Technologies is an Australian medical device company specializing in implantable bioscaffolds for cardiovascular applications, particularly aortic valve and vascular interventions. The company operates at a focused scale with 25 active job openings and a pipeline centered on transcatheter aortic valve replacement (TAVR) technologies.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Cooling — net -6 jobs in 30d
2 added, 8 removed. Slower than typical.
Anteris is a specialized, growth-stage medtech play with meaningful cardiovascular technology ambitions, but limited transparency and scale make it higher-risk than established competitors—best suited for early-career professionals seeking device experience or mission-driven roles willing to accept runway uncertainty.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Anteris Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Anteris Technologies's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles